Y Intercept (Hong Kong) LTD Harmony Biosciences Holdings, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.44 Billion
- Q4 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 27,061 shares of HRMY stock, worth $941,181. This represents 0.06% of its overall portfolio holdings.
Number of Shares
27,061
Previous 6,991
287.08%
Holding current value
$941,181
Previous $279,000
233.69%
% of portfolio
0.06%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$230 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$203 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$165 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$79.3 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$55 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.06B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...